Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$30.27 ... Very nice bounce back from the beating it took a few months ago. I increased my position 4-fold during the beat down. No one care that they are opening a new paper mill.
I am all smiles.
Ground Breaking Ceremony for Orchids Paper Products
Date(s): 6/23/2015
Tuesday, June 23, 2015 | 10am
Airport Industrial Park, at the end of Midfield Road off of Joey Zorn Blvd in Barnwell County, SC.
The City of Barnwell and the County of Barnwell, South Carolina, are pleased to announce a Ground Breaking Ceremony to welcome Orchids Paper Products to our community as they are beginning to build their Barnwell Plant. Barnwell County will also welcome Governor Nikki Haley to speak at this event. The press and the community is welcome to attend this ceremony.
Orchids Paper Products Company Short Interest Up 20.3% in May (TIS)
Posted by mitch on Jun 10th, 2015
The shorts were right about the reaction to the news about the capital raise, but they are wrong long term. TIS is investing in growth. YOY revenues will rise by the end of the year when the first of 3 new paper machines begins operations in the new South Carolina paper mill.
I took advantage ala` Buffett by buying once the news killed the PPS. I quadrupled my position.
Orchids Paper Products Company (NYSE:TIS) was the recipient of a significant increase in short interest in May. As of May 29th, there was short interest totalling 458,629 shares, an increase of 20.3% from the May 15th total of 381,246 shares, AnalystRatings.NET reports. Currently, 5.1% of the company’s shares are short sold. Based on an average trading volume of 114,717 shares, the short-interest ratio is currently 4.0 days.
TIS has been the subject of a number of recent research reports. Analysts at Jefferies Group initiated coverage on shares of Orchids Paper Products Company in a research note on Wednesday, June 3rd. They set a “buy” rating and a $29.00 price target on the stock. Analysts at Oppenheimer initiated coverage on shares of Orchids Paper Products Company in a research note on Monday, May 4th. They set an “outperform” rating and a $27.00 price target on the stock. Analysts at Zacks reiterated a “strong sell” rating on shares of Orchids Paper Products Company in a research note on Friday, May 1st. Finally, analysts at TheStreet downgraded shares of Orchids Paper Products Company from a “buy” rating to a “hold” rating in a research note on Thursday, April 23rd. One analyst has rated the stock with a sell rating, one has given a hold rating and three have assigned a buy rating to the company. The stock presently has a consensus rating of “Hold” and a consensus target price of $30.13.
Orchids Paper Products Company (NYSE:TIS) opened at 22.88 on Wednesday. Orchids Paper Products Company has a 52 week low of $21.42 and a 52 week high of $32.75. The stock has a 50-day moving average of $22. and a 200-day moving average of $26.. The company has a market cap of $234.73 million and a price-to-earnings ratio of 24.58.
Orchids Paper Products Company (NYSE:TIS) last released its earnings data on Monday, April 20th. The company reported $0.16 earnings per share for the quarter, missing the analysts’ consensus estimate of $0.27 by $0.11. The company had revenue of $37.40 million for the quarter, compared to the consensus estimate of $40.00 million. Analysts expect that Orchids Paper Products Company will post $1.28 EPS for the current fiscal year.
Orchids Paper Products Company (NYSE:TIS) is an integrated manufacturer of tissue paper products serving the at home private label consumer market. The Company’s operations in northeast Oklahoma, produces a full line of tissue products, including paper towels, bathroom tissue and paper napkins, to serve the value through premium quality market segments.
I tripled my holdings on the PPS crash. The crash was a mistake based on concerns of dilution. It's a short sighted view. TIS is growing. They're going to use the money raised and twice as much in bank financing to open a new mill in S.C. with 3 paper machines. It's a huge growth story for them. People/investors just have to wait 1 - 2 years for the pay off to be realized. If TIS can maintain their 6.3% dividend, this is going to be a very easy wait.
12% insider ownership.
They're investing in growth, unlike so many Fortune 500 companies that think their best investment is buying back stock.
Best High-Yielding Stocks According To Lynch Principles: Orchids Paper Products
Aug. 9, 2014 8:42 AM ET
http://seekingalpha.com/article/2405205-best-high-yielding-stocks-according-to-lynch-principles-orchids-paper-products
Summary
Ranking the top twenty Russell 3000 dividend paying stocks with higher than 4% yield according to principles of the well-known investor Peter Lynch.
Explanation and back-testing of the "All-Stars: Lynch" ranking system.
Description and a buy recommendation for the first ranked stock of the system, Orchids Paper Products Company.
About half of the Russell 3000 stocks pay dividends. In fact, 1,551 of them pay some dividends, 1,292 companies have a yield greater of 1%, 815 companies have a yield greater of 2%, 473 companies have a yield greater of 3%, and 158 companies have a yield greater of 5%.
A ranking system sorts stocks from best to worst based on a set of weighted factors. Portfolio123 has a powerful ranking system which allows the user to create complex formulas according to many different criteria. They also have highly useful groups of pre-built ranking systems, I used one of them the "All-Stars: Lynch" in this article. The ranking system is based on investing principles of the well-known investor Peter Lynch.
The "All-Stars: Lynch" ranking system is quite complex, and it is taking into account many factors like trailing P/E, relative P/E, PEG ratio, institutional ownership, liabilities, sales growth and EPS growth, as shown in Portfolio123's chart below.
In order to find out how such a ranking formula would have performed during the last 15 years, I ran a back-test, which is available by Portfolio123's screener. For the back-test, I took all the 7,014 stocks in Portfolio123's database.
The back-test results are shown in the chart below. For the back-test, I divided the 7,014 companies into fifty groups according to their ranking. The chart clearly shows that the average annual return has a very significant positive correlation to the "All-Stars: Lynch" rank. This brings me to the conclusion that the ranking system is useful.
After running the "All-Stars: Lynch" ranking system on the companies which are included in the Russell 3000 index and pay a dividend with a higher than 4% yield, on August 08, I discovered the twenty best high-yielding stocks, which are shown in the table below. In this article, I will focus on the first stock in the list, Orchids Paper Products Company (NYSEMKT:TIS). I recommend readers use this list of stocks as a basis for further research. All the data for this article were taken from Yahoo Finance, Portfolio123 and finviz.com.
The Company
Orchids Paper Products Company manufactures and sells tissue products for the at-home market in the United States. The company was founded in 1976 and is headquartered in Pryor, Oklahoma.
Valuation Metrics
The table below presents the valuation metrics of TIS, the data were taken from Yahoo Finance and finviz.com.
Orchids' valuation metrics are very good; the trailing P/E is at 16.81, and the Enterprise Value/EBITDA ratio is low at 10.31. According Yahoo Finance, TIS' next financial year forward P/E is pretty low at 12.73, and the average annual earnings growth estimates for the next five years is very high at 17.0%; these give an extremely low PEG ratio of 0.75. The PEG Ratio - price/earnings to growth ratio is a widely used indicator of a stock's potential value. It is favored by many investors over the P/E ratio because it also accounts for growth. A lower PEG means that the stock is more undervalued.
Latest Quarter Results
On July 23, Orchids reported its second-quarter 2014 financial results, which missed EPS expectations by $0.25 (64%).
Net sales totaled $29.2 million, which were flat compared to the second quarter of 2013. Converted product sales were essentially flat at $27.7 million. Excluding stock compensation and transaction costs, net income was $2.2 million, a decrease of $1.1 million, or 33%, compared with $3.3 million of net income in the same period of 2013. Excluding stock compensation and transaction costs, diluted net income per share for the second quarter 2014 was $0.27 per diluted share compared with $0.42 per diluted share in the same period in 2013.
In the report, Mr. Jeff Schoen, President and Chief Executive Officer, stated:
Despite a challenging sales environment in the first half of 2014 due to increased promotions on branded products affecting private label sales, and inventory reductions at our customers, our focus on product development, new distribution, operational efficiencies, and the Fabrica partnership has positioned us well for future growth and profitability. We believe that the second quarter performance was an anomaly and a strong base of business has been established for the rest of the year that we expect will deliver record results in both sales and earnings for the second half of 2014. Moreover, the Fabrica strategic partnership and the on-going capital projects will increase our ability to produce higher quality grades of value and premium tier products to drive future sales, supporting our vision of being recognized as a national supplier of high quality consumer tissue products in the value, premium, and ultra-premium tier product categories.
Dividend
Orchids has been paying dividends since March 2011. The forward annual dividend yield is very high at 5.21%, and the payout ratio is at 82%.
On July 23, 2014, the board of directors of the company authorized a quarterly cash dividend of $0.35 per outstanding share of the company's common stock. The company expects to pay this dividend on August 18, 2014 to stockholders of record at the close of business on August 4, 2014.
Although the company had excessive cost in the latest quarter, cash used in investing activities was $17.4 million in 2014 compared to $5.6 million in the prior period, its board of directors authorized cash dividend at the same magnitude. Orchids generated cash flow from operating activity in 2013 of about $21 million and $3.1 million in the first six months of 2014.
The decision of the company to keep paying a generous dividend demonstrates that it is a part of Orchids' strategy. Therefore, I believe that the dividend is sustainable.
Technical Analysis
The charts below give some technical analysis information.
The TIS stock price is 8.09% below its 20-day simple moving average, 10.47% below its 50-day simple moving average and 10.41% below its 200-day simple moving average. That indicate a short-term, mid-term, and a long-term downtrend.
The weekly MACD histogram, a particularly valuable indicator by technicians, is negative at -0.38 and descending, which is a bearish signal (a rising MACD histogram and crossing the zero line from below is considered an extremely bullish signal). The RSI oscillator is at 38.16 which do not indicate overbought or oversold conditions.
Analyst Opinion
Only three analysts are covering the stock, two of them rate it as a Strong Buy, and one analyst rates it as a Buy.
Major Developments
On May 05, Orchids announced a strategic alliance with Fabrica de Papel San Francisco to support the growth of Orchids' U.S. west coast sales. Fabrica, which is based in Mexicali, Baja California, Mexico, is a recognized world-class, low cost manufacturer of high-quality tissue paper products. As part of this alliance, Orchids will acquire Fabrica's current U.S. business, including certain manufacturing assets and access to 18,000 metric tons of capacity each year to support the value, premium and ultra-premium requirements of the U.S. market, with an option to purchase an additional 7,000 metric tons in each of the first two years. Products will be produced at Fabrica's facility in Mexicali, Mexico and shipped directly to Orchids' U.S. customers. Orchids will pay an aggregate of $36.7 million under various agreements, including shares of Orchids' common stock having a value of $20 million and cash of $16.7 million, which Orchids expects to fund with a new term loan, discussions of which are proceeding well.
Although the deal with Fabrica involves a big cost for Orchids, it also promises substantial growth prospects for the company. Orchids expects this alliance will allow it to effectively and efficiently service customers in the western United States and support Orchids' vision to become a national supplier of high-quality consumer tissue products in the value, premium and ultra-premium tier markets.
TIS' stock performed very well in 2013 with a 62.4% gain; however, this year it has already lost 18.2%, while the S&P 500 index has risen 3.9%, and the Nasdaq Composite Index has also increased 4.2%. In my opinion, the retreat in its stock price is exaggerated since the second quarter performance was an anomaly and Orchids expects to deliver record results in both sales and earnings for the second half of 2014.
Conclusion
Orchids is poised to benefit from the alliance with Fabrica that should contribute for further growth in revenue and earnings since it opens to the company customers in the western United States.
Orchids has compelling valuation metrics and strong earnings growth prospects; its PEG ratio is very low at 0.75. Furthermore, TIS' stock is ranked first among all Russell 3000 stocks yielding more than 4%, according to Portfolio123's "All-Stars: Lynch" powerful ranking system. In addition, the very generous dividend represents a gratifying income. All these factors bring me to the conclusion that TIS' stock is a smart long-term investment.
Seriously. The PPS is tanking and the CEO buys on the open market. that's news.
Then you check and find out he only owns 5,353 shares.
Big Whoop
TIS is a high dividend payer 4.67%, lightly traded company with only 8.1 MM shares outstanding. Revenues are approximately $120 MM.
http://www.orchidspaper.com/
They acquired the essence of a privately owned Mexican competitor to gain access to their production facility and ownership of their U.S. business/customers. See yellow below.
TIS, primarily services a mid western area within 900 miles of their north eastern headquarters and paper mill. This strategic acquisition expands it's market area all the way to the Pacific Ocean.
Once assimilated, TIS's forward looking revenue and EPS outlook should be updated upwards.
There's been a lot of M & A activity in 2014. This is the model Cisco used to grow so big; acquire other companies and is the same model my trucking company Celadon Group Inc and food company B & G Foods is using to provide value to shareholders.
TIS is followed by 4 companies.
Analyst Information
Firm: Analyst:
Sidoti......................Gunnar Hanson
Singular....................John Curti
Stonegate Securities, Inc...Marco Rodriguez
Taglich Brothers............John Noble
Press Release: Orchids Paper Products Company Enters Strategic Alliance With Fabrica de Papel San Francisco, S.A. de C.V
5:10p ET May 5, 2014 (Dow Jones) PrintPress Release: Orchids Paper Products Company Enters Strategic Alliance With Fabrica de Papel San Francisco, S.A. de C.V
Orchids Paper Products Company Enters Strategic Alliance With Fabrica de Papel San Francisco, S.A. de C.V
PR Newswire
PRYOR, Okla., May 5, 2014
PRYOR, Okla., May 5, 2014 /PRNewswire/ -- Orchids Paper Products Company ("Orchids") (NYSE MKT: TIS) today announced a strategic alliance with Fabrica de Papel San Francisco, S.A. de C.V. ("Fabrica") to support the growth of Orchids' U.S. west coast sales. Fabrica, which is based in Mexicali, Baja California, Mexico, is a recognized world-class, low cost manufacturer of high-quality tissue paper products. Orchids expects this alliance will allow Orchids to effectively and efficiently service customers in the western United States and support Orchids' vision to become a national supplier of high-quality consumer tissue products in the value, premium and ultra-premium tier markets.
Fabrica is a privately owned business which started as a tissue converter in 1958 and has grown to 150,000 metric tons of capacity, one of the largest tissue manufacturers by capacity in Mexico. In 2013, Fabrica started up the world's first NTT paper machine.
As part of this alliance, Orchids will acquire Fabrica's current U.S. business, including certain manufacturing assets and access to 18,000 metric tons of capacity each year to support the value, premium and ultra-premium requirements of the U.S. market, with an option to purchase an additional 7,000 metric tons in each of the first two years. Products will be produced at Fabrica's facility in Mexicali, Mexico and shipped directly to Orchids' U.S. customers. Operating margins on products produced under this agreement are expected to be consistent with margins earned on products produced in Orchids' facility in Oklahoma.
Go to this link to see the actual SC 13D filing
http://www.sec.gov/Archives/edgar/data/1324189/000114420414037675/v381480_sc13d.htm
Orchids Paper Products Company Closes on Agreements With Fabrica de Papel San Francisco, S.A. de C.V.; Enters Into Credit Agreement With U.S. Bank
PRYOR, Okla., June 4, 2014 /PRNewswire/ -- Orchids Paper Products Company ("Orchids") (NYSE MKT: TIS) today announced the closing of the transactions comprising a strategic alliance with Fabrica de Papel San Francisco, S.A. de C.V. ("Fabrica"), as previously discussed in Orchids' press release dated May 5, 2014. This alliance is expected to allow Orchids to effectively and efficiently service customers in the western United States.
Orchids paid an aggregate of $36.7 million under the agreements, consisting of shares of Orchids common stock having a value of $20 million and cash of $16.7 million, which Orchids will fund with a new term loan from U.S. Bank National Association ("U.S. Bank") as discussed below.
"We are excited to begin our partnership with Fabrica," stated Jeffrey Schoen, President and Chief Executive Officer of Orchids. "This alliance is expected to allow us to cost effectively provide high-quality products and superior customer service to a portion of the market that was previously difficult to access. It supports our vision of being recognized as a national supplier of high quality consumer tissue products in the value, premium and ultra-premium tier product categories, and we are confident it will lead to long-term value for our stockholders."
Additionally, Orchids announced its entrance into a credit agreement with U.S. Bank. The $75 million agreement includes a $45 million revolving credit line due June 2019 and a $30 million term loan due June 2020. The agreement has the effect of (i) extending and increasing Orchids' revolving working capital line of credit from $15 million to $25 million, (ii) increasing Orchids' revolving line of credit to include $20 million for the purchase and construction of assets in Oklahoma, and (iii) refinancing and extending Orchids' $10.8 million real estate loan and $7.2 million machinery and equipment loan into a single $30 million term loan, which also provides funding for the $16.7 million to be paid in accordance with the agreements with Fabrica. Borrowings under the agreement will bear interest at variable rates with margins ranging from 1% to 2% above LIBOR.
Please refer to the Orchids Form 8-K filing dated May 5, 2014 for details regarding various agreements of the alliance and the Orchids Form 8-K to be filed with the Securities and Exchange Commission for details regarding the new term loan.
Polsinelli PC represented Orchids and William Blair & Company acted as financial advisors to Orchids on the transactions with Fabrica.
Shares of Orchids Paper Products Rank the Highest in Terms of Dividend Yield in the Household Products Industry (TIS, CLX, PG, KMB, ODC)
May 18, 2014 (SmarTrend(R) News Watch via COMTEX) --
Below are the three companies in the Household Products industry with the highest dividend yields. Dividends can enhance returns for investors seeking income in addition to capital gains.
Orchids Paper Products ranks highest with a a dividend yield of 4.8%. Clorox is next with a a dividend yield of 3.3%. Procter & Gamble ranks third highest with a a dividend yield of 3.2%.
Kimberly-Clark follows with a a dividend yield of 3.0%, and Oil-Dri of America rounds out the top five with a a dividend yield of 2.4%.
SmarTrend is monitoring the recent change of momentum in Oil-Dri of America. Please refer to our Company Overview for the results of our proprietary technical indicators that have been scanning shares of Oil-Dri of America in search of a potential trend change.
Write to Chip Brian at cbrian@mysmartrend.com
SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.MySmarTrend.com
Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.MySmarTrend.com/signup
Copyright, Comtex News Network, Inc. 2014
This law firm is a giant ass hole. They are serial nuisance sue'rs of public companies looking for settlements.
PRESS RELEASE
March 13, 2014, 7:31 p.m. ET
.Faruqi & Faruqi, LLP Announces the Investigation of Orchids Paper Products Company (TIS) For Potential Breaches of Fiduciary Duties by Its Board of Directors .EmailPrinter
FriendlyShare: facebook ? More.
.StumbleUponLinkedInTwitterFarkRedditdel.icio.usMySpace Text
Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Orchids Paper Products Company
NEW YORK, March 13, 2014 /PRNewswire/ -- Juan E. Monteverde, a partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Orchids Paper Products Company ("Orchids" or the "Company") (NYSE MKT: TIS) for potential breaches of fiduciary duties in connection with their conduct in seeking shareholders' approval the Company's 2014 Stock Incentive Plan.
Specifically, in the Proxy Statement filed by the Company with the Securities and Exchange Commission on March 5, 2014, the Board of Directors recommends that Orchids' shareholders vote to approve a grant to approve the Company's 2014 Stock Incentive Plan which would allocate 400,000 shares of Company Stock for issuance thereunder -- and would be separate from the 400,000 shares allocated under the Schoen Option for the Company's President and Chief Executive Officer. The issuance of the additional shares could have a substantial dilutive effect on the shares of Orchids common stock.
Request more information now by clicking here: www.faruqilaw.com/TIS. There is no cost or obligation to you.
Faruqi & Faruqi, LLP is a national law firm which represents investors and individuals in class action litigation. The firm is focused on providing exemplary legal services in complex litigation in the areas of securities, shareholder, antitrust and consumer litigation, throughout all phases of litigation. The firm has an experienced trial team which has achieved significant victories on behalf of the firm's clients. To keep track of the latest securities litigation news, follow us on Twitter at www.twitter.com/MergerActivity or on Facebook at www.facebook.com/FaruqiLaw.
If you own common stock in Orchids and wish to obtain additional information and protect your investments free of charge, please visit us at www.faruqilaw.com/TIS or contact Juan E. Monteverde, Esq. either via e-mail at jmonteverde@faruqilaw.com or by telephone at (877) 247-4292 or (212) 983-9330.
Contact:
Faruqi & Faruqi, LLP
369 Lexington Avenue, 10th Floor
New York, NY 10017
Attn: Juan E. Monteverde, Esq.
jmonteverde@faruqilaw.com
Toll Free: (877) 247-4292
Phone: (212) 983-9330
Attorney Advertising. (C) 2014 Faruqi & Faruqi, LLP. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We are happy to discuss your particular case.
Logo - http://photos.prnewswire.com/prnh/20120119/MM38856LOGO
SOURCE Faruqi & Faruqi, LLP
/Web site: http://www.faruqilaw.com
The Wall Street Journal news department was not involved in the creation of this content. .
~ Wednesday! $TIS ~ Q1 Earnings posted, pending or coming soon! In Charts and Links Below!
~ $TIS ~ Earnings expected on Wednesday *
Want more like this? Search Keyword: MACMONEY >>> http://tinyurl.com/MACMONEY <<<
One or more of many earnings sites has alerted this security has or will be posting earnings on or around the day of this message.
http://stockcharts.com/h-sc/ui?s=TIS&p=D&b=3&g=0&id=p88783918276&a=237480049
http://stockcharts.com/h-sc/ui?s=TIS&p=W&b=3&g=0&id=p54550695994
~ Google Finance: http://www.google.com/finance?q=TIS
~ Google Fin Options: hhttp://www.google.com/finance/option_chain?q=TIS#
~ Yahoo! Finance ~ Stats: http://finance.yahoo.com/q/ks?s=TIS+Key+Statistics
~ Yahoo! Finance ~ Profile: http://finance.yahoo.com/q/pr?s=TIS
Finviz: http://finviz.com/quote.ashx?t=TIS
~ BusyStock: http://busystock.com/i.php?s=TIS&v=2
<<<<<< http://www.earningswhispers.com/stocks.asp?symbol=TIS >>>>>>
http://investorshub.advfn.com/boards/post_prvt.aspx?user=251916
*If the earnings date is in error please ignore error. I do my best.
Orchids Paper Products Company (Orchids) manufactures private label tissue products, including paper towels, bathroom tissue and paper napkins for the consumer or at-home market. It produces bulk tissue paper, known as parent rolls and convert parent rolls into finished products. Orchids product are sold under its customers private labels, such as Colortex, My Size, Velvet, Big Mopper, Tackle and care. The Company uses recycled waste paper to manufacture bulk rolls of tissue paper or parent rolls and convert them into a range of finished tissue products. Its paper mill consists of four machines, which have a total annual capacity of approximately 56,000 tons. Orchids 10 converting lines have a total potential annual capacity of approximately 8.0 million cases of finished tissue products.
http://www.google.com/finance?q=TIS
Followers
|
3
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
164
|
Created
|
04/25/12
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |